Journal
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
Volume 88, Issue 7, Pages 846-849Publisher
WILEY
DOI: 10.1080/00016340902971441
Keywords
Preeclampsia; inflammation; screening; pentraxin
Categories
Funding
- 6th Framework Programme of the European Union [LSHM-CT-2004512040]
- Istituto Superiore di Sanita, MIUR, Ministero della Salute and Fondazione CARIPLO [2005.1055/104878]
Ask authors/readers for more resources
Pentraxin 3 (PTX3) and C-reactive protein (CRP) levels were measured in the first trimester of pregnancy in women who subsequently developed preeclampsia (PE, n=16) and fetal growth restriction (FGR, n=12) requiring iatrogenic delivery before 37 weeks, and those who had uncomplicated pregnancies delivering at term (n=60). Mean PTX3 levels were significantly higher in women who subsequently developed PE (7.31 ng/ml, SD = 4.12) when compared to those with normal pregnancy outcome (4.92 ng/ml, SD = 1.94, p=0.0046). There were no significant differences between PTX3 levels in women with FGR (4.82 ng/ml, SD = 2.35) compared to normal pregnancy outcome (p=0.88). The median CRP levels did not vary significantly between the three groups (p=0.26). PTX3 levels in women who subsequently develop PE are already elevated in the first trimester, but not in those that develop FGR. This supports the hypothesis of an excessive maternal inflammatory response to pregnancy in the etiology of PE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available